bioRxivMicrobiology
Enteric nervous system modulation of luminal pH modifies the microbial environment to promote intestinal health
Abstract
The enteric nervous system (ENS) controls many aspects of intestinal homeostasis, including parameters that shape the habitat of microbial residents. Previously we showed that zebrafish lacking an ENS, due to deficiency of the sox10 gene, develop intestinal inflammation and bacterial dysbiosis, with an expansion of proinflammatory Vibrio strains. To understand the primary defects resulting in dysbiosis in sox10 mutants, we investigated how the ENS shapes the intestinal environment in the absence of microbiota and associated inflammatory responses. We found that intestinal transit, intestinal permeability, and luminal pH regulation are all aberrant in sox10 mutants, independent of microbially induced inflammation. Treatment with the proton pump inhibitor, omeprazole, corrected the more acidic luminal pH of sox10 mutants to wild type levels. Omeprazole treatment also prevented overabundance of Vibrio and ameliorated inflammation in sox10 mutant intestines. Treatment with the carbonic anhydrase inhibitor, acetazolamide, caused wild type luminal pH to become more acidic, and increased both Vibrio abundance and intestinal inflammation. We conclude that a primary function of the ENS is to regulate luminal pH, which plays a critical role in shaping the resident microbial community and regulating intestinal inflammation. Author SummaryThe intestinal microbiota is an important determinant of health and disease and is shaped by the environment of the gut lumen. The nervous system of the intestine, the enteric nervous system (ENS), helps maintain many aspects of intestinal health including a healthy microbiota. We used zebrafish with a genetic mutation that impedes ENS formation to investigate how the ENS prevents pathogenic shifts in the microbiota. We found that mutants lacking an ENS have a lower luminal pH, higher load of pathogenic bacteria, and intestinal inflammation. We showed that correcting the low pH, using the commonly prescribed pharmacological agent omeprazole, restored the microbiota and prevented intestinal inflammation. Conversely, we found that lowering the luminal pH of wild type animals, using the drug acetazolamide, caused expansion of pathogenic bacteria and increased intestinal inflammation. From these experiments, we conclude that a primary function of the ENS is to maintain normal luminal pH, thereby constraining intestinal microbiota community composition and promoting intestinal health.
- organism: zebrafish
- assay: metagenomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut.
H. Zhi, J. Behnsen, … M. Raffatellu·bioRxiv·Jul 20, 2020
- Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrinergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice
Shadi Yarandi, Subhash Kulkarni, … Pankaj Jay Pasricha·GastroenterologyPeer-reviewed·Mar 29, 2020
- The effect of colonic pH on microbial activity and metabolite production using common prebiotics as substrates: an in vitro study
Z. Xie, W. He, … D. S. Nielsen·bioRxiv·Mar 29, 2023
- Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model
Julia Schumacher, Patrick Müller, … Lisa Maier·Gut MicrobesPeer-reviewed·Jun 16, 2025
- Biofilm Formation and Virulence of Shigella flexneri is Modulated by pH of Gastrointestinal Tract
I.-L. Chiang, Y. Wang, … T. Stappenbeck·bioRxiv·Oct 16, 2020
- T cells regulate intestinal motility and shape enteric neuronal responses to intestinal microbiota.
P. R. Marques de Souza, Catherine M. Keenan, … Keith A. Sharkey·Gut MicrobesPeer-reviewed·Dec 20, 2024